Biphenotypic acute leukaemia: a case series
Open Access
- 22 June 2007
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 138 (2), 213-216
- https://doi.org/10.1111/j.1365-2141.2007.06634.x
Abstract
Biphenotypic acute leukaemia (BAL) is a rare type of leukaemia. Whether patients with BAL should be treated with regimens designed for acute myeloid leukaemia (AML), acute lymphocytic leukaemia (ALL) or both remain unclear. We have reviewed the clinical data for 31 BAL patients. Most patients co‐expressed B‐lymphoid and myeloid markers. No specific chromosomal abnormality was identified. The majority of the patients were treated with regimens devised for treating ALL. Seven patients were treated with regimens designed for AML. Complete remission (CR) rates of 78% and 57% were noted respectively. The overall survival probability at 2 years was 60%.Keywords
This publication has 7 references indexed in Scilit:
- Chemoimmunotherapy with hyper‐CVAD plus rituximab for the treatment of adult Burkitt and Burkitt‐type lymphoma or acute lymphoblastic leukemiaCancer, 2006
- Long‐term follow‐up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper‐CVAD), a dose‐intensive regimen, in adult acute lymphocytic leukemiaCancer, 2004
- Mylotarg, fludarabine, cytarabine (ara-C), and cyclosporine (MFAC) regimen as post-remission therapy in acute myelogenous leukemiaCancer Chemotherapy and Pharmacology, 2003
- Gemtuzumab ozogamicin with or without interleukin 11 in patients 65 years of age or older with untreated acute myeloid leukemia and high-risk myelodysplastic syndrome: comparison with idarubicin plus continuous-infusion, high-dose cytosine arabinosideBlood, 2002
- High-dose liposomal daunorubicin and high-dose cytarabine combination in patients with refractory or relapsed acute myelogenous leukemiaCancer, 2001
- Cyclophosphamide, Ara-C and Topotecan (CAT) for Patients With Refractory or Relapsed Acute LeukemiaLeukemia & Lymphoma, 2000
- Clinical significance of the presence of myeloid associated antigens in acute lymphoblastic leukaemiaBritish Journal of Haematology, 1990